Rajendra Prasad Nagarajan

17PUBLICATIONS

21CO-AUTHORS

Molecular targetsPharmaceutical delivery technologiesGene and molecular therapyRadiation therapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (17)

Sort by Publication Date:

|Jun 08, 2026

Deinoxanthin Overcomes P-Glycoprotein-Mediated Multidrug Resistance in Breast Cancer Cells.

|Mar 16, 2026

Drug repurposing in oncology: Bridging computational discovery to clinical application.

Sugumar Baskar, N Rajendra Prasad

|Nov 13, 2024

Solasodine Downregulates ABCB1 Overexpression in Multidrug Resistant Cancer Cells Via Inhibiting Nrf2/Keap1 Signaling Pathway.

Pradhapsingh Bharathiraja, Sugumar Baskar, N Rajendra Prasad

|Oct 09, 2024

Sensitization of Multidrug Resistant Cancer Cells to Doxorubicin Using Ebselen by Disturbing Cellular Redox Status.

Sugumar Baskar, Pradhapsingh Bharathiraja, N Rajendra Prasad

|Feb 21, 2024

Andrographolide reverts multidrug resistance in KBCh<sup>R</sup> 8-5 cells through AKT signaling pathway.

Deepa S Lakra, Pradhapsingh Bharathiraja, T Dhanalakshmi

|Jan 25, 2024

Auranofin sensitizes breast cancer cells to paclitaxel mediated cell death via regulating FOXO3/Nrf2/Keap1 signaling pathway.

N Deepika, N Rajendra Prasad, T Radhiga

Pageof 3

Frequent Collaborators

3 joint publications

Sugumar Baskar

2 joint publications

Pradhapsingh Bharathiraja

Naziya Begum

Priya Yadav

Suresh V Ambudkar

Leonid N Maslov

Sergey V Popov

Alexandr V Mukhomedzyanov

1 joint publications

Sridevi Muruhan

1 joint publications

Vyacheslav V Ryabov

Frequent Collaborators

3 joint publications

Sugumar Baskar

2 joint publications

Pradhapsingh Bharathiraja

1 joint publications

Naziya Begum

1 joint publications

Priya Yadav